Determination of carbendazim, thiabendazole and fuberidazole using a net analyte signal-based method.
The net analyte signal (NAS)-based method HLA/GO, modification of the original hybrid linear analysis (HLA) method, has been used to determine carbendazim, fuberidazole and thiabendazole in water samples. This approach was used after a solid-phase extraction (SPE) step, using the native fluorescence emission spectra of real samples, previously standardized by piecewise direct standardization (PDS). The results obtained show that the modification of HLA performs in a similar way that partial least-squares method (PLS-1). The NAS concept was also used to calculate multivariate analytical figures of merit such as limit of detection, selectivity, sensitivity and analytical sensitivity (gamma(-1)). With this purpose, blanks of methanol and ternary mixtures, with the target analyte at low concentration and the other two ranging according to the calibration matrix, were used, with different results. Detection limits calculated in the last way are more realistic and show the influence of the other components in the sample. Selectivity for carbendazim is higher than the corresponding values for fuberidazole and thiabendazole, whereas sensitivity, as well as the values obtained for their detection limits, are lower for carbendazim, followed by thiabendazole and fuberidazole. Results obtained by modification of HLA vary in the same way that the ones obtained by PLS-1.